Lilia-Celine (Lily) Lozada
Stock Analyst at J.P. Morgan
(1.74)
# 3,487
Out of 4,673 analysts
15
Total ratings
75%
Success rate
3.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine (Lily) Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Maintained: Hold | $36 | $48.98 | -26.50% | 5 | Jul 24, 2026 | |
| NVST Envista Holdings | Maintained: Hold | $26 → $29 | $27.20 | +6.62% | 3 | May 7, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | n/a | $10.92 | - | 2 | Dec 19, 2025 | |
| TMCI Treace Medical Concepts | Downgraded: Sell | $8 → $5 | $4.34 | +15.21% | 5 | Nov 7, 2025 |
AtriCure
Jul 24, 2026
Maintained: Hold
Price Target: $36
Current: $48.98
Upside: -26.50%
Envista Holdings
May 7, 2026
Maintained: Hold
Price Target: $26 → $29
Current: $27.20
Upside: +6.62%
DENTSPLY SIRONA
Dec 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.92
Upside: -
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $4.34
Upside: +15.21%